Potential synergy of antioxidant n-acetylcysteine and insulin in restoring sevoflurane postconditioning cardioprotection in diabetes

Anesthesiology

Volumn 116, Issue 2, 2012, Pages 488-489

  Liu, Ke Xuan ^a   Xia, Zhengyuan ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; GLUCOSE; INSULIN; REMIFENTANIL; SEVOFLURANE; STAT3 PROTEIN; SUPEROXIDE;

DRUG POTENTIATION; GLUCOSE BLOOD LEVEL; HEART PROTECTION; ISCHEMIC POSTCONDITIONING; LETTER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOZOCIN DIABETES; TREATMENT DURATION;

ANIMALS; DIABETES MELLITUS; INSULIN; ISCHEMIC POSTCONDITIONING; MALE; METHYL ETHERS; MYOCARDIAL REPERFUSION INJURY; PHOSPHATIDYLINOSITOL 3-KINASE; STAT3 TRANSCRIPTION FACTOR;

EID: 84856471202     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e31823fd063     Document Type: Letter

References (9)

1. Drenger B, Ostrovsky IA, Barak M, Nechemia-Arbely Y, Ziv E, Axelrod JH: Diabetes blockade of sevoflurane postconditioning is not restored by insulin in the rat heart: Phosphorylated signal transducer and activator of transcription 3-and phosphatidylinositol 3-kinase-mediated inhibition. Anesthesiology 2011; 114:1364-72
2. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000; 404:787-90 (Pubitemid 30212409)
3. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345:1359-67
4. Ouattara A, Lecomte P, Le Manach Y, Landi M, Jacqueminet S, Platonov I, Bonnet N, Riou B, Coriat P: Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients. Anesthesiology 2005; 103: 687-94 (Pubitemid 41415516)
5. Xia Z, Guo Z, Nagareddy PR, Yuen V, Yeung E, McNeill JH: Antioxidant N-acetylcysteine restores myocardial Mn-SOD activity and attenuates myocardial dysfunction in diabetic rats. Eur J Pharmacol 2006; 544:118-25 (Pubitemid 44148577)
6. Boengler K, Buechert A, Heinen Y, Roeskes C, Hilfiker-Kleiner D, Heusch G, Schulz R: Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice. Circ Res 2008; 102:131-5
7. Wang T, Qiao S, Lei S, Liu Y, Ng KF, Xu A, Lam KS, Irwin MG, Xia Z: N-acetylcysteine and allopurinol synergistically enhance cardiac adiponectin content and reduce myocardial reperfusion injury in diabetic rats. PLoS ONE 2011; 6:e23967
8. Xia Z, Qiao S, Liu Y, Wang TT, Mao X, Liu HM, Wong GT, Irwin MG: Antioxidant N-acetylcysteine restores remifentanil preconditioning cardioprotection in rats with streptozotocin-induced diabetes (abstract). Anesth Analg 2011; 112:S-31
9. Kehl F, Krolikowski JG, Weihrauch D, Pagel PS, Warltier DC, Kersten JR: N-acetylcysteine restores isoflurane-induced preconditioning against myocardial infarction during hyperglycemia. Anesthesiology 2003; 98:1384-90 (Pubitemid 36622471)